Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: A pilot study
- 30 April 2008
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 27 (2) , 297-306
- https://doi.org/10.1016/j.clnu.2007.12.003
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Glutamine: Do the Data Support the Cause for Glutamine Supplementation in Humans?Gastroenterology, 2006
- Nutrition and infection in the intensive care unit: what does the evidence show?Current Opinion in HIV and AIDS, 2005
- The role of oxidative stress in adult critical careFree Radical Biology & Medicine, 2005
- Glutamine-enriched enteral nutrition increases in vitro interferon-gamma production but does not influence the in vivo specific antibody response to KLH after severe trauma. A prospective, double blind, randomized clinical studyClinical Nutrition, 2004
- TROPHIC AND CYTOPROTECTIVE NUTRITION FOR INTESTINAL ADAPTATION, MUCOSAL REPAIR, AND BARRIER FUNCTIONAnnual Review of Nutrition, 2003
- Glutamine attenuates post-traumatic glutathione depletion in human muscleClinical Science, 2003
- Glutamine supplementation in serious illness: A systematic review of the evidence*Critical Care Medicine, 2002
- GLUTAMINE DECREASES INTERLEUKIN-8 AND INTERLEUKIN-6 BUT NOT NITRIC OXIDE AND PROSTAGLANDINS E2 PRODUCTION BY HUMAN GUT IN-VITROCytokine, 2002
- Effects of Glutamine Supplementation on Circulating Lymphocytes After Bone Marrow Transplantation: A Pilot StudyThe Lancet Healthy Longevity, 1998
- Impact of Enteral Feeding of a Glutamine-Supplemented Formula on the Hypoaminoacidemic Response in Trauma PatientsThe Journal of Trauma: Injury, Infection, and Critical Care, 1996